show episodes
 
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
  continue reading
 
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
  continue reading
 
Artwork

1
The Top Line

Fierce Life Sciences

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
  continue reading
 
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
  continue reading
 
Welcome to Biotech Bulls & Breakthroughs! This brand new podcast from BioPharmCatalyst explores the dynamic world of biotech investing alongside long-time biotech trader Sheff from Sheff Station. Each month, we will be discussing current events in the biotech industry and how these events impact investors, as well as a discussion of upcoming catalysts in the biotech space.
  continue reading
 
Deep Tech Germany is your front-row seat to the boldest breakthroughs emerging from Germany, Austria, and Switzerland—the DACH region—where advanced research, scientific innovation, and venture capital converge. As part of the Startuprad.io™ network, we spotlight the founders, engineers, scientists, and investors fueling Europe’s deep tech ecosystems. 🌍 Hosted in English for a global audience, this show connects you to the people and platforms building the future of: AI, quantum computing, p ...
  continue reading
 
The Vance Crowe Podcast is a thought-provoking and engaging show where Vance Crowe, a former Director of Millennial Engagement for Monsanto, and X-World Banker, interviews a variety of experts and thought leaders from diverse fields. Vance prompts his guests to think about their work in novel ways, exploring how their expertise applies to regular people and sharing stories and experiences. The podcast covers a wide range of topics, including agriculture, technology, social issues, and more. ...
  continue reading
 
Artwork

1
Life Science Today

Noah Goodson, PhD

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
  continue reading
 
Artwork
 
Welcome to PWS United, a podcast for the Prader-Willi Syndrome community, brought to you by PWSA | USA. This podcast gives the latest news in research, advocacy, and family support by bringing together staff, volunteers, PWS treatment specialists, biotech and pharmaceutical representatives, caregivers, family members, and individuals with PWS. Our goal is to connect education, awareness, and resources with those living with PWS and their supporters. Join us in our mission to enhance the qual ...
  continue reading
 
Artwork

1
Mad Science: The Genetic Crossroad With Anna Kavanaugh

Anna Kavanaugh | Living Eden Media, LLC

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Anna Kavanaugh hosts the weekly radio series, "Mad Science: The Genetic Crossroad." The program aims to raise awareness and provide education about genetically modified organisms (GMO), in the world food supply and the practices of the GM biotech industry. The series is dedicated to all issues surrounding GM foods, its usage and ramifications thereof. Anna is a writer, producer, journalist and advocate. She is the founder of the (AKCF) Anna Kavanaugh Charitable Foundation. Her original novel ...
  continue reading
 
Artwork

1
Say More

The Boston Globe

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
Big ideas and big debates, explained through intimate conversations with the compelling personalities who shape them. AI and biotech. Higher education and health care. Climate and sustainability. Politics and the media. Culture and culture wars. Hosted by Boston Globe columnist Shirley Leung.
  continue reading
 
Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.
  continue reading
 
Artwork

1
Odd Lots

Bloomberg

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
Bloomberg's Joe Weisenthal and Tracy Alloway explore the most interesting topics in finance, markets and economics. Join the conversation every Monday and Thursday.
  continue reading
 
The FYI - For Your Innovation Podcast offers an intellectual discussion on recent developments across disruptive innovation—driven by research, news, controversies, companies, and technological breakthroughs. Hosted by ARK Invest, ARK and guests provide a unique perspective on how to best understand disruptive innovation.
  continue reading
 
Artwork

1
BioBiz Buzz

https://biobizbuzz.com/

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries. Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences. Disclaimer https://biobizbuzz.com/disclaimer/
  continue reading
 
Tech Uncensored, Crucial Analysis in Tech, is a bi-weekly podcast brought to you by Altitude Accelerator. Hosted by Hessie Jones, we explore emerging news, and relevant topics that startups care about. We speak to subject matter experts, founders and advisors in Investment: Venture Capital, Equity Crowdfunding, and across Industry: Clean Tech, Biotech, Generative AI, Blockchain, Web3, Privacy, Security etc. who weigh in on the challenges that startup founders face today, as well as the profo ...
  continue reading
 
Women Who Rock GSA is your front-row seat to the women redefining entrepreneurship and innovation in the DACH region. As part of the award-winning Startuprad.io™ network, this sub-podcast celebrates female founders, investors, and trailblazers from Germany, Austria, and Switzerland—all delivered in English for a global audience. 🎧 Ranked among the Top 20 Global Entrepreneurship Podcasts on Apple, this series uncovers the untold stories, strategic insights, and powerful journeys of women tran ...
  continue reading
 
Artwork

1
BloodStream

BloodStream Media

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
BloodStream is an entertaining and informational podcast for the bleeding disorders community. Each week, hemophilia patient Patrick James Lynch and former non-profit director Amy Board are joined by advocacy leaders, medical experts, and other guests to discuss the latest news, scientific advancements, policy initiatives, and so much more. Subscribe wherever you listen, or search BloodStream Podcast on YouTube to catch every episode there. Produced by Believe Limited. Presenting sponsor: Ta ...
  continue reading
 
Artwork

1
Asia Insight

National Bureau of Asian Research

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Podcasts from The National Bureau of Asian Research (NBR) covering the critical issues that leaders need to understand – because the decisions they make matter and the stakes are high.
  continue reading
 
Artwork

1
The Art of Digitalisation

E-Estonia Briefing Centre

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Welcome to The Art of Digitalisation, a podcast brought to you by one of the most digital countries on earth, e-Estonia. Directly from the heart of the e-Estonia secret headquarters. Or briefing centre as we actually call it. In every episode, we bring you digitalisation experts from across the globe, sharing their expertise and advice on how they transformed businesses, governments, and more, using innovation through technology. Whether you’re taking your first steps on your own digitalisat ...
  continue reading
 
Accessing (and keeping) talent in today’s biotechnology sector isn’t easy. There’s no question that biotech, life sciences, and the medical field in general experienced massive acceleration since March 2020. More treatments have been approved, biotech investment reached record heights, and thousands of new companies entered the landscape, heralding unprecedented growth in just about every aspect of the sector – bio health, bioenergy, bio-industrial, and agri-bio.In this podcast, Rob Henderso ...
  continue reading
 
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
  continue reading
 
Artwork

1
Equity

TechCrunch, Mary Ann Azevedo, Kell, Theresa Loconsolo, Rebecca Bellan, Kirsten Korosec, Devin Coldewey, Margaux MacColl

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
The intersection of technology, startups, and venture capital touches everything now. That’s why Equity, TechCrunch's flagship podcast, digs into the business of startups for entrepreneurs and enthusiasts alike. Every Wednesday and Friday, TechCrunch reporters keep you up-to-date on the world of business, technology, and venture capital. Equity is ranked the No.2 podcast in the Top 100 Venture Capital All time leaderboard on Goodpods—As well as No.17 for the Top 100 Finance All time chart an ...
  continue reading
 
Loading …
show series
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Former FDA official Peter Marks criticized the agency's new risk-based COVID-19 vaccine framework, stating it contradicts the administration's transparency and science standards. The CDC's advisory committee recommended M…
  continue reading
 
The story of US tariffs has dominated much of the conversation for markets. Earlier today, stocks advanced Thursday in a sign investors are shifting their focus from concerns about lower growth and higher inflation from tariffs to instead prepare for corporate earnings season, which starts in a few days. We speak to Keith Buchanan, Senior Portfolio…
  continue reading
 
A divergence in the tech space, as software stocks trail the chipmakers. What it means for the broader market, and if the underperforming software sector can catch up. And speaking of underperforming, Target trailing Walmart in a major way over the past year. Why the big box retailers are heading in different directions, and what the Chartmaster se…
  continue reading
 
On this week’s episode of the Readout LOUD: A closer look at the NIH’s grant-cutting legal playbook, a not-so-transparent transparency push by the FDA commissioner, and another big biotech acquisition. Our colleague Anil Oza joins us to unravel a previously unseen memo he obtained from HHS that lays out the legal framework being used to justify the…
  continue reading
 
Lisata Therapeutics Inc CEO Dr David Mazzo and GATC Health chief business officer Tyrone Lam talked with Proactive's Stephen Gunnion about the companies' collaboration to advance a novel treatment for opioid use disorder. Mazzo explained that combining Lisata’s regulatory and clinical expertise with GATC’s MAT artificial intelligence platform allow…
  continue reading
 
Manx Financial Group (AIM:MFX) CEO Douglas Grant talked with Proactive about the company’s record 2024 results and plans for continued expansion. Grant shared that Manx Financial Group delivered a 41% jump in profits last year, driven by three main growth areas: Conister Bank’s strong liquidity, Payment Assist’s accelerating lending volumes, and Ma…
  continue reading
 
London BTC Company Ltd (LSE:BTC, OTCQB:VINZF) CEO Hewie Rattray talked with Proactive's Stephen Gunnion about the company’s £1.5 million capital raise and how it plans to deploy these funds to build its Bitcoin holdings. Rattray explained that nearly all of the capital will be used to increase the company’s Bitcoin stack over the next six to twelve…
  continue reading
 
Chesnara PLC (LSE:CSN) chief executive Steve Murray talked with Proactive's Stephen Gunnion about the company’s £260 million agreement to acquire HSBC Life UK’s insurance business. The deal, set to complete in early 2026, will see over 450,000 policyholders join Chesnara and bring approximately £4 billion of assets under administration.Murray said,…
  continue reading
 
Fineqia International Inc (CSE:FNQ, OTC:FNQQF) CEO Bundeep Singh Rangar talked with Proactive about the strong early traction of the Fineqia Bitcoin Yield ETP (YBTC). YBTC has quickly surpassed C$15 million in assets under management, driven by what Rangar described as a “triangulation” of factors: high demand for bitcoin, Europe’s regulatory frame…
  continue reading
 
Savannah Resources PLC (AIM:SAV, ETR:SAV, OTC:SAVNF) CEO Emanuel Proença talked with Proactive's Stephen Gunnion about the company’s progress at its Barroso Lithium Project in northern Portugal. Savannah Resources is a junior miner fully permitted to develop a lithium spodumene resource that Proença described as “the only sizable and competitive re…
  continue reading
 
Georgina Energy PLC (LSE:GEX) chief financial officer Mark Wallace talked with Proactive's Stephen Gunnion about the company’s recent financial results delay and its strategic plans for natural gas development. Wallace explained that the delay was due to the complex reverse takeover of Mining, Minerals & Metals PLC and the subsequent re-listing pro…
  continue reading
 
Oriole Resources PLC CEO Martin Rosser talked with Proactive's Stephen Gunnion about the company's announcement of a significant maiden exploration target at its Mbe project in Cameroon. The milestone was achieved in under nine months from the start of the maiden drilling. Rosser explained that the independent consultant Forge estimated a median to…
  continue reading
 
In this episode of Asia Insight, NBR President Michael Wills is joined by Rear Admiral Mike Studeman (U.S. Navy, ret.) and Ms. Cathy Johnston as they assess the People's Liberation Army ahead of the Chinese Communist Party's goal to build a world-class military by 2049. Cathy Johnston spent 33 years in the Intel Community mostly focused on Asia. He…
  continue reading
 
In this episode of FYI, Chief Futurist, Brett Winton, and Analyst Nemo Marjanovic speak with Alex Zhavoronkov, founder and CEO of Insilico Medicine. Together, they explore the promise of artificial intelligence in transforming the drug discovery process—cutting years off timelines and dramatically reducing costs. Alex shares Insilico’s journey from…
  continue reading
 
For investors, geopolitical risks are always lurking as a factor that could upend trades for obvious reasons. When war breaks out, it's crucial to have some kind of understanding of what it will mean for various markets (such as oil or grain) and how long the conflict can persist. But is there any way to analyze these things scientifically? Many pe…
  continue reading
 
It's a uniquely challenging time for our nation's medical community. The Trump administration has set its sites on slashing federal funding for healthcare and research by tens of billions of dollars, which could be catastrophic for the NIH and CDC. Funding is tenuous to say the least. Then there's mounting political pressure to restrict access to c…
  continue reading
 
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Merck recently made a significant move in the pharmaceutical industry by acquiring Verona for $10 billion, gaining access to the commercial COPD drug Ohtuvayre. This acquisition is viewed as a strategic decision to offse…
  continue reading
 
Bitcoin surged past $112,000 for the first time, setting a fresh record alongside a broad rally in risk assets that has swept up technology stocks big and small. The original cryptocurrency rose as much as 3.1% to $112,009, pushing its gain this year close to 20%. The move underscores the speculative momentum gripping markets even as President Dona…
  continue reading
 
Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to announce the successful deployment of the company’s PowerBuoy® system in Monterey Bay, California, in support of the Naval Postgraduate School. This latest installation is part of a previously announced contract and represents a strategic leap forward in integrati…
  continue reading
 
Nvidia becomes the first company to cross the $4T market cap, as the chip giant helps fuel the Nasdaq to its own record high. How the semi surge is fueling the broader tech trade, and if the gains can continue. Plus Is it time for an Apple turnover? Why one Wall Street research firm thinks it’s time for Tim Cook to be replaced, and how a new chief …
  continue reading
 
Andrew Horowitz of The Disciplined Investor breaks down the ultimate winner of the Big, Beautiful Bill… how to manage volatility in growth stocks… whether AI is a threat to Google… one mega-cap AI stock he’s long—and one he’s short. In this episode: Welcome back, Andrew Horowitz, host of The Disciplined Investor [0:16] How’s the economy? Depends on…
  continue reading
 
“SaaS is going away,” says Dave Park, co-founder and CEO of Narada AI. The company is betting on a future where AI agents, not humans, navigate enterprise software on our behalf. Today on Equity, Park joins Rebecca Bellan on Equity to talk about the rise of agentic AI, what it actually is, how it differs from traditional automation, and what real-w…
  continue reading
 
In this episode of the Xtalks Life Science Podcast, host Ayesha Rashid speaks with Edwin Tucker, MD, MBA, Chief Medical Officer (CMO) at Jasper Therapeutics, about innovative approaches to treating chronic mast cell diseases such as asthma, food allergies and IBS. Dr. Tucker has over 30 years of clinical drug development experience, with past roles…
  continue reading
 
Southwest Airlines is taking generic drugmakers to court and accusing more than 20 companies of price fixing that inflated costs for millions of Americans, including its own employees. In this episode of The Biotech Brief, we unpack the lawsuit, the history of generic drug cartel behavior, and why drug developers (yes, even biotech innovators) shou…
  continue reading
 
Arizona Gold and Silver CEO Mike Stark joined Steve Darling from Proactive to announce a notable high-grade vein intercept from the company’s ongoing drill program at the Philadelphia Project in Arizona. Drill hole PC25-154, located in the Perry Zone, intersected 22.47 metres grading 3.05 grams per tonne (g/t) gold, including 1.59 metres grading 11…
  continue reading
 
Templeton Emerging Markets Investment Trust PLC (LSE:TEM) Vice President, Senior Product Specialist Sri Chandran joined Stephen Gunnion in the Proactive studio to discuss the trust's approach to investing in global emerging markets.TEMIT, the UK’s oldest and largest emerging markets investment trust, aims to deliver long-term capital appreciation b…
  continue reading
 
Galliford Try Holdings PLC (LSE:GFRD) Chief Financial Officer Kris Hampson takes Proactive's Stephen Gunnion through the company's trading update and future growth prospects. Hampson explained that Galliford Try has grown by roughly a third over the last two years, driven by strong performance in highways and water infrastructure. "We expect that t…
  continue reading
 
Celadon Pharmaceuticals PLC (AIM:CEL) CEO and co-founder James Short talked with Proactive's Stephen Gunnion about the company’s strategic plans, including a potential delisting from AIM and the development of its proprietary API (active pharmaceutical ingredient). He noted, “The delisting is something that we've been looking at for several months …
  continue reading
 
Plexus Holdings PLC (AIM:POS) CEO Craig Hendrie talked with Proactive's Stephen Gunnion about the company’s focus on rental wellhead operations and strategic growth in the Middle East. Hendrie explained that over the past year, Plexus reoriented its strategy to prioritise the rental wellhead business, putting complex products on hold to accelerate …
  continue reading
 
Bitwise Asset Management European Head talked with Proactive's Stephen Gunnion about Bitcoin’s recent price performance and the launch of a new staking ETP. Bradley Duke explained that Bitcoin has been trading near all-time highs, noting: “There’s real momentum pushing Bitcoin to make new all-time highs.” He highlighted how demand from ETFs, ETPs, …
  continue reading
 
Cobalt Blue Ltd chief executive officer Dr Andrew Tong talked with Proactive about the recent three-year extension to major project status for the Broken Hill Cobalt Project. Dr Tong explained that this extension provides crucial time to advance the project to a financing decision, particularly as cobalt prices have declined over the past few years…
  continue reading
 
HANetf head of research Tom Bailey talked with Proactive's Stephen Gunnion about the performance and outlook for the Future of Defence UCITS ETF (LSE:NATO), which has reached approximately £2.7 billion in assets under management, up from £700 million at the start of the year. He attributed this growth to geopolitical developments, including rising …
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Medical societies, including the American Academy of Pediatrics, have filed a lawsuit against RFK Jr. over changes to COVID-19 vaccine policies. They argue that his directive to remove COVID-19 from vaccination guidelines…
  continue reading
 
President Donald Trump vowed to push forward with his aggressive tariff regime in the coming days, stressing he would not offer additional extensions on country-specific levies set to now hit in early August while indicating he could announce substantial new rates on imports of copper and pharmaceuticals. The posturing on social media and at a Cabi…
  continue reading
 
Big banks head lower as investors scoop up beaten down sectors like small caps, healthcare, and airlines. Could the next great rotation in the market be underway? Plus Coreweave shedding some of its gains after the company announced a data deal, and the acquisition is fueling Wall Street pessimism on the name. What one top analyst sees in store for…
  continue reading
 
The latest in PWSA | USA events and PWS news in research, family support, and advocacy. 24 Hour Crisis Line: 941-312-0400 United in Hope Conference United in Hope—and Action: Reflections from the International Prader-Willi Syndrome Conference 2025 United in Hope International PWS Conference - YouTube PWSA | USA 50th Birthday Party Drone Show Submit…
  continue reading
 
Loading …

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play